Viracta Therapeutics, Inc. (VIRX)

NASDAQ: VIRX · IEX Real-Time Price · USD

0.548

-0.003 (-0.45%)

At close: Jul 19, 2024, 4:00 PM

0.550

+0.003 (0.46%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Viracta Therapeutics Market Cap

Viracta Therapeutics has a market cap or net worth of $21.50 million as of July 22, 2024. Its market cap has decreased by -55.94% in one year.

Market Cap

21.50M

Enterprise Value

792.64K

1-Year Change

-55.94%

Ranking

#4922

Market Cap Chart

Since September 27, 2005, Viracta Therapeutics's market cap has decreased from $139.50M to $21.50M, a decrease of -84.59%. That is a compound annual growth rate of -9.46%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	21.50M	-2.27%
Dec 29, 2023	22.00M	-60.57%
Dec 30, 2022	55.80M	-59.03%
Dec 31, 2021	136.20M	278.33%
Dec 31, 2020	36.00M	-4.26%
Dec 31, 2019	37.60M	141.03%
Dec 31, 2018	15.60M	-87.66%
Dec 29, 2017	126.40M	67.20%
Dec 30, 2016	75.60M	11.67%
Dec 31, 2015	67.70M	-57.15%
Dec 31, 2014	158.00M	-38.26%
Dec 31, 2013	255.90M	18.31%
Dec 31, 2012	216.30M	295.43%
Dec 30, 2011	54.70M	-60.48%
Dec 31, 2010	138.40M	276.09%
Dec 31, 2009	36.80M	234.55%
Dec 31, 2008	11.00M	-83.89%
Dec 31, 2007	68.30M	-48.53%
Dec 29, 2006	132.70M	24.13%
Dec 30, 2005	106.90M	-23.37%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Minerva Neurosciences	21.96M
Gain Therapeutics	21.84M
Aprea Therapeutics	21.72M
OneMedNet	21.70M
Spruce Biosciences	21.61M
Forte Biosciences	21.50M
TherapeuticsMD	21.22M
AIM ImmunoTech	21.16M

Market Cap Rankings